ATE135407T1 - Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper - Google Patents

Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper

Info

Publication number
ATE135407T1
ATE135407T1 AT91919407T AT91919407T ATE135407T1 AT E135407 T1 ATE135407 T1 AT E135407T1 AT 91919407 T AT91919407 T AT 91919407T AT 91919407 T AT91919407 T AT 91919407T AT E135407 T1 ATE135407 T1 AT E135407T1
Authority
AT
Austria
Prior art keywords
peptides
antibodies
hiv
induce
retrovirus
Prior art date
Application number
AT91919407T
Other languages
English (en)
Inventor
Luc Montagnier
Danielle Berneman
Denise Guetard
Elmostafa Bahraoui
Rietschoten Jurphaas Van
Solange Chamaret
Alain Blanchard
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9013324A external-priority patent/FR2668488A1/fr
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE135407T1 publication Critical patent/ATE135407T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1253—Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91919407T 1990-09-27 1991-09-27 Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper ATE135407T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9011951 1990-09-27
FR9013324A FR2668488A1 (fr) 1990-10-26 1990-10-26 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides.

Publications (1)

Publication Number Publication Date
ATE135407T1 true ATE135407T1 (de) 1996-03-15

Family

ID=26228256

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919407T ATE135407T1 (de) 1990-09-27 1991-09-27 Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper

Country Status (8)

Country Link
EP (2) EP0550691B1 (de)
AT (1) ATE135407T1 (de)
CA (1) CA2092546A1 (de)
DE (1) DE69117965T2 (de)
DK (1) DK0550691T3 (de)
ES (1) ES2087311T3 (de)
GR (1) GR3020185T3 (de)
WO (1) WO1992006199A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773293A (en) * 1992-01-27 1998-06-30 Icos Corporation Anti-ICAM-4 antibodies and hybridomas
US5700658A (en) * 1992-01-27 1997-12-23 Icos Corporation ICAM-4 materials and methods
US5753502A (en) * 1993-08-05 1998-05-19 Icos Corporation Neuron-specific ICAM-4 promoter
FR2696186B1 (fr) * 1992-09-28 1994-12-02 Pasteur Institut Souches de Mycoplasma. fermentans cytopathogène et procédés de diagnostic in vitro et d'immunisation mettant en Óoeuvre de telles souches.
FR2705970B1 (fr) * 1993-06-04 1995-08-04 Pasteur Institut Identification du gène de l'adhésine de M. Pirum.
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
CN1423698A (zh) 1999-11-16 2003-06-11 真那特应用生物科技有限公司 Hiv－1亚型间(c/b’)基因组和其用途
EP2905031A1 (de) * 2014-02-10 2015-08-12 B Cell Design Neues, nicht-HIV-Impfstoff-Antigen aus der vaginalen Mikrobiota zur Induzierung einer mukosalen, neutralisierenden, schützenden Antikörperreaktion gegen eine HIV-Infektion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945041A (en) * 1983-11-17 1990-07-31 Board Of Regents Monoclonal antibodies for Mycoplasma pneumoniae and use for diagnosis of pneumonia
EP0387915B1 (de) * 1984-10-18 1993-03-10 Institut Pasteur F Antigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen

Also Published As

Publication number Publication date
WO1992006199A3 (fr) 1992-05-29
WO1992006199A2 (fr) 1992-04-16
CA2092546A1 (fr) 1992-03-28
DK0550691T3 (da) 1996-07-29
EP0550691B1 (de) 1996-03-13
ES2087311T3 (es) 1996-07-16
EP0550691A1 (de) 1993-07-14
GR3020185T3 (en) 1996-09-30
EP0736542A1 (de) 1996-10-09
DE69117965D1 (de) 1996-04-18
DE69117965T2 (de) 1996-11-14

Similar Documents

Publication Publication Date Title
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
AU1353295A (en) Peptides derived from a retrovirus of the HIV group, and their use
RU2012106150A (ru) Вариантные формы уратоксидазы и их применение
DK1218751T3 (da) Cöliakidiagnose under anvendelse af et gliadinepitop
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
ATE168719T1 (de) Osteogene peptide
DE69117965D1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
ATE403726T1 (de) Cytokin-proteinfamilie
FI892185A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
DK0579363T3 (da) Behandling af tropisk spastisk parese med peptid T
ATE90108T1 (de) Vasokonstriktor-peptid.
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
KR920012114A (ko) 사람 면역결핍 바이러스(HIV)의 그룹-특이 항원(gaa)의 선택된 펩타이드, 이의 제법 및 용도
ATE521635T1 (de) Physiologisch wirksamer komplex mit tnf aktivität
DK0426314T3 (da) HIV-relaterede peptider
RU2009123462A (ru) Гомогенные препараты il-28 и il-29
ECSP003720A (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee